Canada markets closed

Palantir Technologies Inc. (PLTR)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
7.24+0.02 (+0.28%)
At close: 04:00PM EST
7.22 -0.02 (-0.28%)
After hours: 06:19PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close7.22
Open7.37
Bid0.00 x 40700
Ask0.00 x 2200
Day's Range7.04 - 7.45
52 Week Range5.84 - 14.86
Volume27,926,941
Avg. Volume32,665,845
Market Cap15.061B
Beta (5Y Monthly)2.88
PE Ratio (TTM)N/A
EPS (TTM)-0.25
Earnings DateFeb 13, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est8.79
  • Motley Fool

    This Fast-Growing Tech Company Expects to Add Staff This Year

    At the World Economic Forum in Davos, Palantir CEO Alex Karp said that it may hire a couple hundred workers this year, even as many tech companies continue to cut staff. In Palantir's most recent quarterly results, it reported revenue of $478 million for the period ending Sept. 30, 2022, which equaled a year-over-year increase of 22%. Many big tech companies that are laying off staff deal with consumer-related products and services.

  • Motley Fool

    After a Brutal 2022, Is Time Up for Palantir Stock?

    After two decades of staying privately held, big-data analytics company Palantir Technologies (NYSE: PLTR) went public in Sept. 2020. While the company boasts several U.S. government agencies as well as brand-name commercial sector companies on its client roster, Wall Street has expressed concerns about Palantir's near-term growth rate. Palantir is off to a great start in 2023, and although some of the analyst concerns are valid, its valuation looks appealing for long-term investors.

  • Bloomberg

    Peter Thiel Says British Affection for NHS Is Stockholm Syndrome

    (Bloomberg) -- Billionaire entrepreneur and investor Peter Thiel, whose data analytics company Palantir Technologies Inc. is vying for a £480 million ($595 million) National Health Service data contract, has described British people’s affection for the state-backed health service as “Stockholm syndrome.” Most Read from BloombergUS Confronts China Over Companies’ Ties to Russian War EffortCitadel’s $16 Billion Win Tops Paulson’s Greatest Trade EverNYSE Investigates Technical Issue That Caused Wil